These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24466023)

  • 1. Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro.
    Rombach-Riegraf V; Karle AC; Wolf B; Sordé L; Koepke S; Gottlieb S; Krieg J; Djidja MC; Baban A; Spindeldreher S; Koulov AV; Kiessling A
    PLoS One; 2014; 9(1):e86322. PubMed ID: 24466023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.
    Karle A; Spindeldreher S; Kolbinger F
    MAbs; 2016; 8(3):536-50. PubMed ID: 26817498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.
    Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S
    Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Walsh RE; Lannan M; Wen Y; Wang X; Moreland CA; Willency J; Knierman MD; Spindler L; Liu L; Zeng W; Rocha GV; Obungu V; Lu J; Kaliyaperumal A; Ferrante A; Siegel R; Malherbe LP
    MAbs; 2020; 12(1):1764829. PubMed ID: 32370596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity.
    Siegel M; Bolender AL; Ducret A; Fraidling J; Hartman K; Looney CM; Rohr O; Hickling TP; Kettenberger H; Lechmann M; Marban-Doran C; Kraft TE
    Front Immunol; 2024; 15():1406643. PubMed ID: 39263220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
    Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
    Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of
    Morgan H; Tseng SY; Gallais Y; Leineweber M; Buchmann P; Riccardi S; Nabhan M; Lo J; Gani Z; Szely N; Zhu CS; Yang M; Kiessling A; Vohr HW; Pallardy M; Aswad F; Turbica I
    Front Immunol; 2019; 10():601. PubMed ID: 31001248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
    Jäger E; Jäger D; Karbach J; Chen YT; Ritter G; Nagata Y; Gnjatic S; Stockert E; Arand M; Old LJ; Knuth A
    J Exp Med; 2000 Feb; 191(4):625-30. PubMed ID: 10684854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.
    Saito K; Ait-Goughoulte M; Truscott SM; Meyer K; Blazevic A; Abate G; Ray RB; Hoft DF; Ray R
    J Virol; 2008 Apr; 82(7):3320-8. PubMed ID: 18216090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation.
    Schjetne KW; Thompson KM; Aarvak T; Fleckenstein B; Sollid LM; Bogen B
    Int Immunol; 2002 Dec; 14(12):1423-30. PubMed ID: 12456590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides.
    Hsu DH; Paz P; Villaflor G; Rivas A; Mehta-Damani A; Angevin E; Zitvogel L; Le Pecq JB
    J Immunother; 2003; 26(5):440-50. PubMed ID: 12973033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of immunostimulatory stem-cell- and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretion.
    Bykovskaia SN; Shurin GV; Graner S; Bunker ML; Olson W; Thomas R; Shurin MR; Marks S; Storkus WJ; Shogan J
    Stem Cells; 2002; 20(5):380-93. PubMed ID: 12351809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
    Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
    Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.
    Zehn D; Cohen CJ; Reiter Y; Walden P
    Eur J Immunol; 2004 Jun; 34(6):1551-60. PubMed ID: 15162424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells.
    Dieckmann D; Schultz ES; Ring B; Chames P; Held G; Hoogenboom HR; Schuler G
    Int Immunol; 2005 May; 17(5):621-35. PubMed ID: 15824067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response.
    Osada T; Nagawa H; Takahashi T; Tsuno NH; Kitayama J; Shibata Y
    J Immunother; 2002; 25(2):176-84. PubMed ID: 12074047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.